Last updated September 1, 2026
Key finding
Total glucose AUC decreased by 36.1 mg/dL/180 min, p=0.0500.
This study evaluated the impact of probiotic supplementation on glucose control in adults with type 2 diabetes, showing some improvements in glucose metrics.
Quick read
The essential study design details in one scan.
EvidenceScore™
Moderate
Study type
RCTs
Follow-up
Medium-Term (3–12 mo)
Risk of bias
Some Concerns
Save research, organize studies, and quickly find important evidence again.
Plain-language summary
A plain-language read of the study’s main message and where it applies.
Study focus
This study evaluated the impact of probiotic supplementation on glucose control in adults with type 2 diabetes, showing some improvements in glucose metrics.
Improving postprandial glucose control is crucial for managing type 2 diabetes, as elevated glucose levels can lead to serious health complications. This study suggests that probiotics could be a beneficial addition to dietary strategies aimed at better glucose management, potentially leading to improved patient outcomes.
Unclear effectiveness for some outcomes. Small sample size may limit generalizability. Short duration of the study may not capture long-term effects.
Published in
Publication details and source links for this paper.
Fanny P, Paul M, James B, et al. Probiotic supplementation improves postprandial glucose control in adults with type 2 diabetes: a randomized controlled trial. BMJ Open Diabetes Research & Care. 2020;8(1):e001319. doi:10.1136/bmjdrc-2020-001319
Total glucose AUC decreased by 36.1 mg/dL/180 min, p=0.0500.
A1c decreased by 0.6%, p=0.0540.
Incremental glucose AUC decreased by 28.6 mg/dL/180 min, p=0.0066.
Evidence network
Understand where this research contributes within the broader evidence network.
This study contributes evidence to WBF-011 and Glucose area under the curve (AUC), HbA1c.
This study contributes evidence to
Primary intervention
WBF-011
Primary outcomes
Evidence topics
Primary intervention
Primary outcomes
Intervention and outcome relationships this study adds to the evidence network.
Editorial context
See why this paper is useful beyond its individual results.
Evidence network role
This section describes how the study fits into the current evidence network. It does not determine whether an intervention works on its own.
3
Related topics
2
Evidence pairs
1264
Related studies
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Evidence topic
Contributes evidence
Save studies and evidence pages, organize your personal Evidence Tracker, and keep the research you care about in one place.
Primary evidence
Evidence topic
matched_outcome
Related evidence
Evidence topic
Save evidence
Core evidence
The primary outcomes reported in this study.
WBF-011 → Glucose area under the curve (AUC)
WBF-011 → Glucose area under the curve (AUC)
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Evidence Library
Save research, organize studies, and quickly find important evidence again.
Explore related studies, evidence collections, and research questions.
Relationships organized using the Dediabetes Evidence Intelligence™ framework.
This study contributes to evidence on WBF-011 and Postprandial and OGTT Glucose, WBF-011 and HbA1c.
This study contributes to the evidence on the following intervention-outcome relationships.
Supplements
Supplements
Curated evidence collections and hubs this study is part of.
All studies measuring HbA1c
Measures HbA1c as a key outcome.
All studies measuring Postprandial and OGTT Glucose
Measures Postprandial and OGTT Glucose as a key outcome.
All studies on WBF-011
Contributes to WBF-011 evidence base.
Jump to pre-filtered views in Evidence Explorer.
1 results
1 results
1 results
1 results
1 results
Generated from the study's connected evidence using Evidence Intelligence™.
WBF-011 appears to improve glucose area under the curve (AUC).
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
Glucose area under the curve (AUC)
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | strong positive | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Current evidence does not show a clear benefit of WBF-011 for HbA1c.
ConsistencyScore™: Consistency cannot yet be determined from the available evidence.
Ranked evidence signals
HbA1c
EvidenceScore™ Emerging | EvidenceScore™ 59.0 | neutral | ConsistencyScore™ Unclear | 1 study
Why this answer: This answer is based on a single supporting study.
Limitations
Next steps
Choose a next path through related evidence topics, Evidence Explorer views, and research summaries.
Follow the topics this study contributes to.
Open broader Evidence Explorer views for this relationship.
Read related research summaries.
Focused on evidence, not advertising.
Your data is always protected.
New studies added every day.
